Jeff Ajer
2015
In 2015, Jeff Ajer earned a total compensation of $3.8M as Executive Vice President, Chief Commercial Officer at BioMarin Pharmaceutical, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $323,606 |
|---|---|
| Option Awards | $1,259,291 |
| Salary | $445,193 |
| Stock Awards | $1,712,088 |
| Other | $16,500 |
| Total | $3,756,678 |
Ajer received $1.7M in stock awards, accounting for 46% of the total pay in 2015.
Ajer also received $323.6K in non-equity incentive plan, $1.3M in option awards, $445.2K in salary and $16.5K in other compensation.
Rankings
In 2015, Jeff Ajer's compensation ranked 2,364th out of 13,638 executives tracked by ExecPay. In other words, Ajer earned more than 82.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,364 out of 13,638 | 83rd |
Division Manufacturing | 849 out of 5,190 | 84th |
Major group Chemicals And Allied Products | 307 out of 1,854 | 83rd |
Industry group Drugs | 243 out of 1,528 | 84th |
Industry Pharmaceutical Preparations | 191 out of 1,182 | 84th |
Source: SEC filing on April 25, 2017.
Ajer's colleagues
We found four more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2015.
2015
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2015
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2015
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2015
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019